Pacira Biosciences
PCRX
#6309
Rank
โ‚ฌ0.88 B
Marketcap
22,39ย โ‚ฌ
Share price
0.80%
Change (1 day)
5.59%
Change (1 year)
Categories

Earnings for Pacira Biosciences (PCRX)

Earnings in 2026 (TTM): โ‚ฌ15.15 Million

According to Pacira Biosciences 's latest financial reports the company's current earnings are โ‚ฌ0.74 Billion. In 2025 the company made an earning of โ‚ฌ14.98 Million, an increase over its 2024 earnings that were of -โ‚ฌ56.06 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Pacira Biosciences from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ15.15 M1.13%
2025 โ‚ฌ14.98 M-126.74%
2024 -โ‚ฌ56.06 Million-202.28%
2023 โ‚ฌ54.8 M363.85%
2022 โ‚ฌ11.81 M-76.42%
2021 โ‚ฌ50.1 M180.76%
2020 โ‚ฌ17.84 M-286.92%
2019 -โ‚ฌ9.55 Million2428.94%
2018 -โ‚ฌ0.38 Million-99%
2017 -โ‚ฌ37.73 Million12.23%
2016 -โ‚ฌ33.62 Million-1885.05%
2015 โ‚ฌ1.88 M-115.65%
2014 -โ‚ฌ12.04 Million-78.95%
2013 -โ‚ฌ57.17 Million21.55%
2012 -โ‚ฌ47.03 Million41.18%
2011 -โ‚ฌ33.31 Million57.4%
2010 -โ‚ฌ21.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Zogenix
ZGNX
-โ‚ฌ0.19 Billion-1,301.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
โ‚ฌ3.34 M-78.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
โ‚ฌ14.19 M-9.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-โ‚ฌ70.53 Million-549.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-โ‚ฌ30.25 Million-292.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-โ‚ฌ55.78 Million-455.80%๐Ÿ‡บ๐Ÿ‡ธ USA